Yet evidently it is most of the IDSA Lyme Guidelines' co-authors, along with several insurance companies, who are on trial for alleged RICO violations.
https://dockets.justia.com/docket/texas/txedce/5:2017cv00190/179306
Many consider this a political label. Case in point: The longest running study on chronic Lyme that I am aware of was started back in 1998 or 1999. For 15 or so years it was referred to as the Chronic Lyme study.
Toady, I believe that study remains ongoing, but it appears to now be called a...
It is perhaps more accurate to have written, "It is undisputed that a portion of patients with lyme disease continue having symptoms after the infection has been treated with a conventional course of antibiotics."
That "portion" is widely acknowledged to be 10-20%.
Start googling around 1985...
Of course, trial variables can be manipulated in such a fashion as to still enable biases to tip the scales.
A general rule of thumb, but precisely the rub in some medical communities,i.e. clinicians with apparently good reason can, in some instances, doubt the voracity (integrity?) of the...
Wow. Very cool!
I should not have qualified early days. That was poorly worded. I should have said have there ever been indications of MS outbreaks, or the such.
For those who think MS is an immune dysfunction of sorts, or auto-immune, how would they explain this, I wonder?
I don't think that's quite accurate. As you say, there may be many paths to ME; some of those paths may not have to lend themselves to outbreaks, e.g., be contageous, or have a shared trigger like mass trial vaccine. Some clearly would.
I wonder if in the early days of reporting MS there were...
Some people get ME in outbreaks. Many with ME are not part of any known outbreak.
The operative phase here is "we know about". We are learning more about channelopathies all the time. It could be that some are triggered by insults such as infections; maybe not. Ultimately, what is rare relative...
Why? I actually doubt it is genetic as well, but I am curious as to why you make this statement. It seems that almost once a month a new genetic marker is stumbled upon that suggests a form of channelopathy, so, I'm curious as to why you say this?
Agreed, except I'm unclear how it works other...
Before they did anything, they should have performed the same metrics on HC and late stage Lyme (as opposed to early Lyme) and what they call PTLDS to see if there were any differences between LS Lyme and PTLDS. I suspect there would have been no meaningful differences.
If that is the case...
I qualified for both the ME/CFS and Lyme parts of this study, and was in fact recruited to participate. Somewhere along the line it was decided I could not participate since I did in fact have both diseases.
In a way, for me at least, that pretty much sums up the results.
Is this just a case of suggesting the rooster makes the sun rise?
Inference is no longer a strength of mine, but that deficit seems endemic in medicine so I don't feel too lonely.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.